De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.

Autor: Androdias G; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Centre de Ressources, Recherche et Compétence sur la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Lyon-Bron, France.; Clinique de la Sauvegarde, Ramsay Santé, 69009 Lyon, France., Lünemann JD; University and University Hospital Münster, Department of Neurology with Institute of Translational Neurology, 48149 Münster, Germany., Maillart E; Department of Neurology, Multiple sclerosis center, Pitié-Salpêtrière Hospital, AP-HP, 47 bd de l'Hôpital, 75013 Paris, France., Amato MP; Departmente NEUROFARBA, University of Florence, 50139 Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, 50143 Florence, Italy., Audoin B; Department of Neurology, University hospital of Marseille, 13005 Marseille, France.; Aix Marseille University, CNRS, CRMBM, 13385 Marseille Cedex 5, France., Bruijstens AL; Department of Neurology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands., Bsteh G; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria., Butzkueven H; Department of Neuroscience, School of Translational Medicine, Monash University, 3004 Melbourne, Australia.; Department of Neurology, Alfred Health, 3004 Melbourne, Australia., Ciccarelli O; Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.; National Institute for Health and Care Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London WC1B 5EH, UK., Cobo-Calvo A; Department of Neurology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Derfuss T; Departments of Neurology and Biomedicine, University Hospital Basel, 4031 Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Basel, 4031 Basel, Switzerland., Di Pauli F; Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Edan G; Department of Neurology, University Hospital of Rennes, 35033 Rennes, France.; CIC-P 1414 INSERM, University Hospital of Rennes, 35033 Rennes, France., Enzinger C; Department of Neurology, Medical University of Graz, 8010 Graz, Austria., Geraldes R; NMO service, Department of Neurology, Oxford University Hospitals, Oxford OX3 9DU, UK.; Nuffield Department of Clinical Neurosciences, Oxford University, Oxford OX3 9DU, UK., Granziera C; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Basel, 4031 Basel, Switzerland.; Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.; Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, 4031 Basel, Switzerland., Hacohen Y; Queen Square MS Centre, Department of Neuroinflammation, Faculty of Brain Sciences, UCL Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.; Department of Neurology, Great Ormond Street Hospital for Children, London WC1N 3JH, UK., Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.; Brain and Mind Center, Medical Faculty, University of Sydney, Sydney NSW 2050, Australia.; Department of Neurology, Palacky University Olomouc, 77900 Olomouc, Czech Republic., Hynes S; School of Health Sciences, College of Medicine, Nursing and Health Sciences, University of Galway, Galway H91 TK33, UK., Inglese M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132 Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Basel, 4031 Basel, Switzerland.; Departments of Head Spine and Neuromedicine, Biomedicine, Research and Biomedical Engineering, University Hospital Basel and University of Basel, 4031 Basel, Switzerland., Kuusisto H; Tampere University Hospital, department of Neurology, 33520 Tampere, Finland.; University of Eastern Finland, faculty of social and welfare management, 70211 Kuopio, Finland., Langer-Gould A; Neurology Department, Los Angeles Medical Center, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA 90027, US., Magyari M; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, 2600 Glostrup, Denmark.; Danish Multiple Sclerosis Registry, Copenhagen University Hospital - Rigshospitalet, 2600 Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark., Marignier R; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Centre de Ressources, Recherche et Compétence sur la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Lyon-Bron, France.; Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Lyon-Bron, France., Montalban X; Department of Neurology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; UVIC-UCC Universitat Central de Catalunya, 08500 Vic, Spain., Mycko MP; Department of Neurology, University of Warmia and Mazury, 10719 Olsztyn, Poland., Nourbakhsh B; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore 21287, MD, USA., Oh J; Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, M5B1W8 Toronto, Canada., Oreja-Guevara C; Department of Neurology, Hospital Clinico San Carlos, IdISSC, 28040 Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain., Piehl F; Department of Clinical Neuroscience, Karolinska Institute, and Department of Neurology, Karolinska University Hospital, S171 76 Stockholm, Sweden., Prosperini L; MS Unit, S. Camillo-Forlanini Hospital, 00152 Rome, Italy., Sastre-Garriga J; Department of Neurology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, 2600 Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark., Selmaj K; Department of Neurology, University of Warmia and Mazury, 10719 Olsztyn, Poland.; Center of Neurology, 90-324 Lodz, Poland., Siva A; Istanbul University Cerrahpasa School Of Medicine, Clinical Neuroimmunology Unit & MS Clinic, Department Of Neurology, 34098 Istanbul, Turkey., Tallantyre E; Department of Neurology, University Hospital of Wales, Cardiff CF14 4XW, UK.; Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff CF14 4XN, UK., van Pesch V; Cliniques Universitaires Saint-Luc, UCLouvain, 1200 Brussels, Belgium., Vukusic S; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Centre de Ressources, Recherche et Compétence sur la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Lyon-Bron, France.; Université de Lyon, Université Claude Bernard Lyon 1, 69100 Lyon-Villeurbanne, France.; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, 69677 Lyon-Bron, France.; Eugène Devic EDMUS Foundation against multiple sclerosis, 69500 Bron, France., Weinstock-Guttman B; Jacobs School of Medicine and Biomedical Sciences, SUNY University at Buffalo, UB Neurology, Buffalo 14203, NY, USA., Zipp F; Department of Neurology, Focus Program Translational Neuroscience (FTN), and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany., Tintoré M; Department of Neurology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; UVIC-UCC Universitat Central de Catalunya, 08500 Vic, Spain., Iacobaeus E; Department of Clinical Neuroscience, Karolinska Institute, and Department of Neurology, Karolinska University Hospital, S171 76 Stockholm, Sweden., Stankoff B; Department of Neurology, Multiple sclerosis center, Pitié-Salpêtrière Hospital, AP-HP, 47 bd de l'Hôpital, 75013 Paris, France.; Sorbonne Université, Paris Brain Institute, ICM, Inserm, CNRS, Hôpital de la Pitié Salpêtrière AP-HP, 75013 Paris, France.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Dec 21. Date of Electronic Publication: 2024 Dec 21.

MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis.

Autor: Hämäläinen P; From the Department of Psychology and Speech-Language Pathology, University of Turku, Turku, Finland.; The Finnish Neuro Society, Masku, Finland.; StellarQ Ltd, Turku, Finland., Viitala M; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; StellarQ Ltd, Turku, Finland., Kuusisto H; Department of Neurology, Tampere University Hospital, Tampere, Finland.; Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland., Ruutiainen J; Division of Clinical Neurosciences, University of Turku, Turku, Finland.; The Finnish Neuro Society, Masku, Finland.; Turku University Hospital Neurocenter, Turku, Finland., Soilu-Hänninen M; Division of Clinical Neurosciences, University of Turku, Turku, Finland.; Turku University Hospital Neurocenter, Turku, Finland.

Publikováno v: International journal of MS care [Int J MS Care] 2024 Oct 07; Vol. 26 (Q4), pp. 273-280. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024).

Experiences of Decision Making and Attitudes Toward Digital Health Services Among Older Adults in Finland.

Autor: Rosenlund M; Department of Health and Social Management, University of Eastern Finland, Finland., Turja T; Faculty of Social Sciences, Tampere University, Finland., Jylhä V; Department of Health and Social Management, University of Eastern Finland, Finland.; Research Centre for Nursing Science and Social and Health Management, Kuopio University Hospital, Finland., Saranto K; Department of Health and Social Management, University of Eastern Finland, Finland., Kuusisto H; Department of Health and Social Management, University of Eastern Finland, Finland.; Tampere University Hospital, Finland.

Publikováno v: Studies in health technology and informatics [Stud Health Technol Inform] 2024 Aug 22; Vol. 316, pp. 216-220.

Shared decision-making endorses intention to follow through treatment or vaccination recommendations: a multi-method survey study among older adults.

Autor: Turja T; Faculty of Social Sciences, Tampere University, Kalevantie 5, Tampere, 33014, Finland. tuuli.turja@tuni.fi., Rosenlund M; Faculty of Social Sciences and Business Studies, Department of Health and Social Management, University of Eastern Finland, Yliopistonranta 1 F, Kuopio, 70211, Finland., Jylhä V; Faculty of Social Sciences and Business Studies, Department of Health and Social Management, University of Eastern Finland, Yliopistonranta 1 F, Kuopio, 70211, Finland.; Wellbeing Services County of North Savo, Research Centre for Nursing Science and Social and Health Management, Kuopio University Hospital, Puijonlaaksontie 2, Kuopio, 70211, Finland., Kuusisto H; Faculty of Social Sciences and Business Studies, Department of Health and Social Management, University of Eastern Finland, Yliopistonranta 1 F, Kuopio, 70211, Finland.; Department of Neurology, Tampere University Hospital, Tampere, Finland.

Publikováno v: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2024 Jul 23; Vol. 24 (1), pp. 202. Date of Electronic Publication: 2024 Jul 23.

Asymptomatic subjects differ less from their twin siblings with MS than from healthy controls in cognitive functioning. A Finnish Twin Cohort study

Autor: Kuusisto, H., Vahvelainen, T., Hämäläinen, P., Luukkaala, T., Elovaara, I.

Publikováno v: In Journal of the Neurological Sciences 15 June 2016 365:50-53